Recruiting NCT06929442
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
In United States Schizophrenia, Anxiety Behavioral From 18 Years to 30 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Schizophrenia, Anxiety Recruiting NCT05081596
This study is recruiting in the United States. It focuses on depression.
In United States Depression Behavioral Over 60 Years
Countries United States
Sponsor Weill Medical College of Cornell University
Condition Depression Recruiting NCT03887715
This study is recruiting in the United States. It is testing VNS Therapy® System for treatment-resistant depression.
In United States Depression Device i A study involving a tool, app, wearable, test, or medical device. Over 18 Years
Countries United States
Sponsor LivaNova
Condition Depression Recruiting NCT06115746
This study is recruiting in the United States. It focuses on Addiction.
In United States Addiction Behavioral From 9 Years to 22 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Addiction Recruiting NCT05943171
This study is recruiting in the United States. It focuses on Addiction.
In United States Addiction Behavioral From 18 Years to 65 Years
Countries United States
Sponsor University of Rochester
Condition Addiction Recruiting NCT06906939
This study is recruiting in the United States. It focuses on depression.
In United States Depression Behavioral From 50 Years to 95 Years
Countries United States
Sponsor University of California, Los Angeles
Condition Depression Recruiting NCT07172516
This study is recruiting in the United States. It is testing azetukalner for depression in bipolarity.
In United States Bipolarity, Depression Drug i A study involving a medication or substance. From 18 Years to 74 Years
Countries United States
Sponsor Xenon Pharmaceuticals Inc.
Condition Bipolarity, Depression Recruiting NCT06775379
This study is recruiting in the United States. It is testing azetukalner for depression.
In United States Depression Drug From 18 Years to 74 Years
Countries United States
Sponsor Xenon Pharmaceuticals Inc.
Condition Depression Recruiting NCT07076407
This study is recruiting in the United States, in Finland, in Poland, .... It is testing azetukalner for depression.
In United States Depression Drug From 18 Years to 74 Years
Countries United States, Finland, Poland, ...
Sponsor Xenon Pharmaceuticals Inc.
Condition Depression Recruiting NCT05562557
This summary needs review. Please check the official study record and contact the research team for details.
In United States Addiction Behavioral Over 18 Years
Countries United States
Sponsor Montefiore Medical Center
Condition Addiction Recruiting NCT06586619
This summary needs review. Please check the official study record and contact the research team for details.
In United States Depression Behavioral From 50 Years to 75 Years
Countries United States
Sponsor Florida International University
Condition Depression Recruiting NCT06817863
This summary needs review. Please check the official study record and contact the research team for details.
In United States Eating disorders Behavioral From 18 Years to 70 Years
Countries United States
Sponsor Drexel University
Condition Eating disorders